EUR-Lex & EU Commission AI-Powered Semantic Search Engine
Modern Legal
  • Query in any language with multilingual search
  • Access EUR-Lex and EU Commission case law
  • See relevant paragraphs highlighted instantly
Start free trial

Similar Documents

Explore similar documents to your case.

We Found Similar Cases for You

Sign up for free to view them and see the most relevant paragraphs highlighted.

Case T-238/15: Judgment of the General Court of 21 September 2017 — Novartis v EUIPO — Meda (Zimara) (EU trade mark — Opposition proceedings — Application for the EU word mark Zimara — Earlier EU word mark FEMARA — Relative ground for refusal — Article 8(1)(b) of Regulation (EC) No 207/2009 — Article 75 of Regulation No 207/2009 — Article 76(1) of Regulation No 207/2009 — Obligation to decide on the entirety of the appeal — First sentence of Article 64(1) of Regulation No 207/2009)

ECLI:EU:UNKNOWN:62015TA0238

62015TA0238

September 21, 2017
With Google you find a lot.
With us you find everything. Try it now!

I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!

Valentina R., lawyer

Official Journal of the European Union

C 374/27

(Case T-238/15) (<span class="super note-tag">1</span>)

((EU trade mark - Opposition proceedings - Application for the EU word mark Zimara - Earlier EU word mark FEMARA - Relative ground for refusal - Article 8(1)(b) of Regulation (EC) No 207/2009 - Article 75 of Regulation No 207/2009 - Article 76(1) of Regulation No 207/2009 - Obligation to decide on the entirety of the appeal - First sentence of Article 64(1) of Regulation No 207/2009))

(2017/C 374/40)

Language of the case: English

Parties

Applicant: Novartis AG (Basle, Switzerland) (represented by M. Douglas, lawyer)

Defendant: European Union Intellectual Property Office (represented by H. O’Neill, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO: Meda AB (Solna, Sweden)

Re:

Action brought against the decision of the Fifth Board of Appeal of EUIPO of 6 March 2015 (Case R 636/2014-5) relating to opposition proceedings between Novartis and Meda.

Operative part of the judgment

The Court:

1.Annuls the Decision of the Fifth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 6 March 2015 (Case R 636/2014-5) in so far as the Board of Appeal failed to rule on the appeal before it as regards ‘veterinary preparations’;

2.Dismisses the remainder of the action;

3.Orders each party to bear its own costs.

(<span class="super">1</span>) OJ C 228, 13.7.2015.

EurLex Case Law

AI-Powered Case Law Search

Query in any language with multilingual search
Access EUR-Lex and EU Commission case law
See relevant paragraphs highlighted instantly

Get Instant Answers to Your Legal Questions

Cancel your subscription anytime, no questions asked.Start 14-Day Free Trial

At Modern Legal, we’re building the world’s best search engine for legal professionals. Access EU and global case law with AI-powered precision, saving you time and delivering relevant insights instantly.

Contact Us

Tivolska cesta 48, 1000 Ljubljana, Slovenia